Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Revolution Medicines Inc (RVMD)

Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Revolution Medicines Closes $862.5 Million Underwritten Public Offering of Common Stock

Revolution Medicines closed a public offering of 16.6 million shares, raising $862.5 million for RAS-addicted cancer therapies.Quiver AI SummaryRevolution Medicines, Inc. has successfully completed its...

RVMD : 44.06 (+1.78%)
Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares

RVMD : 44.06 (+1.78%)
Revolution Medicines Prices Public Offering of Common Stock and Pre-Funded Warrants, Aiming for $750 Million in Proceeds

Revolution Medicines announced a public offering of 14.1 million shares priced at $46 each, aiming for $750 million proceeds.Quiver AI SummaryRevolution Medicines, Inc., a clinical-stage oncology company...

RVMD : 44.06 (+1.78%)
Revolution Medicines Announces Pricing of Upsized $750.0 Million Public Offering of Common Stock and Pre-Funded Warrants

RVMD : 44.06 (+1.78%)
Revolution Medicines, Inc. Provides Promising Clinical Updates on RMC-6236 for RAS-Addicted Cancers

Revolution Medicines provides updates on RMC-6236 and RMC-6291 in clinical trials for RAS-addicted cancers.Quiver AI SummaryRevolution Medicines, Inc. provided a clinical update on its RAS(ON) inhibitor...

RVMD : 44.06 (+1.78%)
Revolution Medicines Announces Commencement of Public Offering of Common Stock

RVMD : 44.06 (+1.78%)
Revolution Medicines Provides Clinical Updates from its RAS(ON) Inhibitor Portfolio

RVMD : 44.06 (+1.78%)
Revolution Medicines to Host Investor Webcast on RAS(ON) Inhibitor Clinical Updates

Revolution Medicines will host an investor webcast on December 2, 2024, to discuss updates on its RAS(ON) inhibitor portfolio.Quiver AI SummaryRevolution Medicines, Inc., a clinical-stage oncology company...

RVMD : 44.06 (+1.78%)
Revolution Medicines to Host RAS(ON) Inhibitor Clinical Update Webcast on December 2, 2024

RVMD : 44.06 (+1.78%)
Revolution Medicines Reports Third Quarter 2024 Financial Results and Update on Corporate Progress

RVMD : 44.06 (+1.78%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar